C3 Glomerulonephritis

Nephrology

Prevalence

0.5 / 100K

Incidence

6.8 / 100K/yr

0 drugs in development·0 companies·4 clinical trials

Frequently asked questions

How many clinical trials target C3 Glomerulonephritis?

There are 4 clinical trials targeting C3 Glomerulonephritis tracked by BioSniper.

What is the prevalence of C3 Glomerulonephritis?

The estimated prevalence of C3 Glomerulonephritis is approximately 0.5 per 100,000 population.

Deep-dive into C3 Glomerulonephritis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    C3 Glomerulonephritis — Drugs in Development & Clinical Trials | BioSniper